Page last updated: 2024-11-05

zonisamide and Spinocerebellar Ataxias

zonisamide has been researched along with Spinocerebellar Ataxias in 3 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Spinocerebellar Ataxias: A group of predominately late-onset, cerebellar ataxias which have been divided into multiple subtypes based on clinical features and genetic mapping. Progressive ataxia is a central feature of these conditions, and in certain subtypes POLYNEUROPATHY; DYSARTHRIA; visual loss; and other disorders may develop. (From Joynt, Clinical Neurology, 1997, Ch65, pp 12-17; J Neuropathol Exp Neurol 1998 Jun;57(6):531-43)

Research Excerpts

ExcerptRelevanceReference
"Early-onset severe spinocerebellar ataxia 42 with neurodevelopmental deficits (SCA42ND, MIM#604065) is an ultrarare autosomal dominant syndrome related to de novo CACNA1G gain-of-function pathogenic variants."1.62Early-onset severe spinocerebellar ataxia 42 with neurodevelopmental deficits (SCA42ND): Case report, pharmacological trial, and literature review. ( Bolasell, M; Casas-Alba, D; Fernández-Fernández, JM; López-Sala, L; Mari-Vico, R; Martínez-Monseny, AF; Martorell, L; Muchart, J; Pérez-Ordóñez, M; Serrano, M, 2021)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Casas-Alba, D1
López-Sala, L1
Pérez-Ordóñez, M1
Mari-Vico, R1
Bolasell, M1
Martínez-Monseny, AF1
Muchart, J1
Fernández-Fernández, JM1
Martorell, L1
Serrano, M1
Hara, N2
Morino, H2
Matsuda, Y1
Satoh, K1
Hashimoto, K1
Maruyama, H2
Kawakami, H2
Nezu, T1
Kobatake, K1

Other Studies

3 other studies available for zonisamide and Spinocerebellar Ataxias

ArticleYear
Early-onset severe spinocerebellar ataxia 42 with neurodevelopmental deficits (SCA42ND): Case report, pharmacological trial, and literature review.
    American journal of medical genetics. Part A, 2021, Volume: 185, Issue:1

    Topics: Age of Onset; Alleles; Calcium Channels, T-Type; Child, Preschool; Epilepsy; Female; Gain of Functio

2021
Zonisamide can ameliorate the voltage-dependence alteration of the T-type calcium channel Ca
    Molecular brain, 2020, 11-26, Volume: 13, Issue:1

    Topics: Calcium Channels, T-Type; Dihydropyridines; Electrophysiological Phenomena; HEK293 Cells; Humans; Mu

2020
Treatment of intractable resting tremor of spinocerebellar ataxia 42 with zonisamide.
    Journal of the neurological sciences, 2019, 01-15, Volume: 396

    Topics: Adult; Anticonvulsants; Calcium Channels, T-Type; Cerebellum; Female; Humans; Mutation; Spinocerebel

2019